Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

Takeda has unveiled new Phase 3 data for Ninlaro in the treatment of newly diagnosed transplant ineligible multiple myeloma, revealing that the...
The FDA has green-lit Boehringer Ingelheim’s multi-targeted tyrosine kinase inhibitor Ofev (nintedanib) in the treatment of chronic fibrosing...
The British Government has outlined its emergency legislation to tackle coronavirus in which people could leave work to become volunteers to care for...
The FDA has moved to authorise Isturisa (osilodrostat) in patients who are ineligible for pituitary gland surgery or are still affected by the...
Eli Lilly is asking some of its employees to work from home to stop the spread of coronavirus on its Indianapolis campus.
Uganda is preparing to enter the final stages of developing a new HIV treatment to reduce stigma and discrimination of those living with the disease.
NICE, the NHS’ drug watchdog in England and Wales, has announced its decision not to recommend Sanofi and Regeneron’s IL-4 inhibitor Dupixent (...
The coronavirus continues to threaten the global drug market, with disruption to the US drug production pipeline from the coronavirus potentially...
New research has pinned a concrete figure on the perennial industry question: how much does it cost to bring a new drug product through development...
China has moved to authorise Roche’s Actemra (tocilizumab) as a treatment for severe complications from contracting the COVID-19 coronavirus in a...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches